A meta-analysis didn't find an association between famotidine use and severe disease or death from COVID-19, and the association of these outcomes with proton-pump inhibitors varied by study type.
A retrospective cohort study compared amoxicillin-clavulanate with metronidazole-fluoroquinolone and found no differences in outcomes including risks for inpatient admission or surgery, while Clostridioides difficile risk appeared higher in older patients on the latter regimen.
The global prevalence of metabolic dysfunction-associated fatty liver disease, a newly proposed term for nonalcoholic fatty liver disease, is “astonishingly high,” the authors of a recent meta-analysis found.
This month's quiz asks readers to manage a 6-cm fluid collection with solid debris in the body of the pancreas in a 48-year-old man presenting to the ED with left flank pain and dysuria six months after hospitalization for severe acute gallstone pancreatitis.
Coverage of the American College of Gastroenterology's annual meeting in the February ACP Internist and ACP Hospitalist offered advice on managing patients with persistent gastroesophageal reflux disease (GERD) and recognizing acute colonic pseudo-obstruction.
A French trial found that 34% of patients who received rifaximin before and after placement of a transjugular intrahepatic portosystemic shunt (TIPS) had hepatic encephalopathy versus 53% of those who received placebo, with no differences in adverse events or transplant-free survival.
Preliminary results from a safety clinical trial indicate that tofacitinib may be associated with an increased risk of serious heart-related events and cancer compared to tumor necrosis factor inhibitors.